Baby Food Market (By Category: Organic, Conventional; By Types: Milk Formula, Dried, Ready-to-Feed, Other; By Distribution Channel: Drugstores/Pharmacies, Supermarkets/Hypermarkets, Convenience Store, Online Channels, Other; By Ingredients: Fats and Oils, Lactose, Protein, Flour, Flavour Enhancer, Vitamins & Minerals, Others; By Formulation: Powder, Liquid; By Health Benefit) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032
The global baby food market size was estimated at USD 83.92 billion in 2022 and is expected to hit around USD 155.32 billion by 2032, growing at a CAGR of 6.4% during the forecast period 2023 to 2032.
To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics
The increased awareness on innovative food products, organized retail marketing activities and increased number of working mothers, decreasing infant mortality rate and increasing parental concerns are all responsible for the growth of this market. During the pandemic, the parents were more conscious about the health of their babies and even though there were lockdowns across the nations the growth in this market has been seen even during the pandemic. In order to provide the infants with organic and healthier supplements and food products, the parents across the world are investing only in these food products. The baby food is soft, easily digestible meal which is created by keeping in mind the human babies aged between 4 to 6 months or up till two years of age.
Growth Factors
The demand for the organic baby food is increasing as the number of women working has increased in the recent years. There is a great demand for these convenient foods which is leading to a growth in the market. Due to a lack of time for home administration, the modern households are shifting to the use of these packed baby foods which are easy to prepare and packed with nutrients. This industry is expected to see a growth as it helps in saving time and also helps in maintaining a work life balance for the women while they take care of their domestic work. The nutritional requirements of the children are the priority of any woman. When it comes to working women, they choose the manufactured baby meals, which are resulting in the expansion of this industry. As the food manufacturers are increasing their expenditure on greater quality and inexpensive organic food materials there shall be a growth in the market.
Due to the increasing population of infants and the increased penetration of organic baby food the market is expected to grow during the forecast period. The baby food is usually packed in various forms such as powder, liquid or paste, depending upon the requirement of the babies. There is adoption of the baby food across the globe as it helps in developing the brain, the nervous system, the muscles and helps in creating an awareness regarding the benefits of the nutrients it offers.
Report Scope of the Baby Food Market
Report Coverage | Details |
Market Size in 2023 | USD 88.87 Billion |
Market Size by 2032 | USD 155.32 Billion |
Growth Rate from 2023 to 2032 |
CAGR of 6.4% |
Largest Market | Asia Pacific |
Online Distribution Channel Segment Growth Rate | 13.2% from 2023 to 2032 |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Segments Covered | Category, Types, Distribution Channel, Ingredients, Formulation, Health Benefit, Geography |
Companies Mentioned | Nestlé (Gerber Products Company), Danone S.A., Reckitt Benckiser (Mead Johnson & Company, LLC), Abbott, Feihe International Inc., Fries land Campina, Bellamy's Organic, Kraft Heinz, HiPP GmbH & Co. Vertrieb KG, Perrigo, Arla Food |
Category Insights
On the basis of category, the baby food market can be segmented into organic and conventional foods. Although the organic baby food is extremely good quality and have more nutrition value, but they are expensive, so this is a setback in the growth for this market. The conventional foods have shown a good growth in the previous years and it is expected to grow during the forecast period.
Type Insights
On the basis of the type of the baby food, the market can be segmented into dried baby food, ready to feed baby food, milk formula, and other types. The ready to eat baby food product accounts for the largest share in terms of revenue. It includes porridge, purees, squash. All these food items are ready to eat. As the number of working women is increasing in the economics across the world, the segment is expected to grow.
Apart from this, the dried food segment, which includes the cereals, fruits and vegetables, should also see a growth during the forecast period. The dried baby food segment is expected to grow at a CAGR of 13% as they have a good shelf life and they are easy to prepare.
Distribution Channel Insights
On the basis of the distribution channel, the hypermarket or the supermarket segment is expected to have the largest share, in the overall market it happens to have 35% of the total market size. As there is a great awareness and popularity of these food products amongst the people of the Asia Pacific region the supermarkets are expected to grow during the forecast. This segment provides aggressive marketing and lucrative pricing schemes.
Apart from the supermarkets, the online distribution channel is also expected to grow during the forecast. The online distribution channel is expected to have CAGR of 13.2% during the forecast period.
Regional Insights
The Asia Pacific market had the largest revenue in the previous years and it is expected to exhibit promising gains during the forecast period. As there is an increase in the working women population and an awareness of various baby food products that provide the nutrition and ensure the health of the babies the market is expected to grow. Due to diverse distribution options and strong marketing channels, the market shall grow during the forecast.
As a large number of raw material providers for the baby food are present in the European region. Stringent regulations and cutthroat competition among the manufacturers had led to a diversification in the product portfolio and an increase in the nutritional value of the food. The major players are actively engaged in mergers and acquisitions in order to provide a competitive edge. The global players also ensure partnership with the medium,small retailers or enterprise in order to provide the preferred baby food. Lot of revenue is spent on marketing and creating awareness regarding the products that these companies offer. So, the global food market is expected to grow during the forecast.
Key Market Players
Key Market Developments
Segments covered in the report.
(Note*: We offer report based on sub segments as well. Kindly, let us know if you are interested)
By Category
By Types
By Distribution Channel
By Ingredients
By Formulation
By Health Benefit
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Health Benefit Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Baby Food Market
5.1. COVID-19 Landscape: Baby Food Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Baby Food Market, By Category Type
8.1. Baby Food Market, by Category Type, 2023-2032
8.1.1. Organic
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Conventional
8.1.2.1. Market Revenue and Forecast (2021-2032)
Chapter 9. Global Baby Food Market, By Types
9.1. Baby Food Market, by Types Type, 2023-2032
9.1.1. Milk Formula
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Dried
9.1.2.1. Market Revenue and Forecast (2021-2032)
9.1.3. Ready-to-Feed
9.1.3.1. Market Revenue and Forecast (2021-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2021-2032)
Chapter 10. Global Baby Food Market, By Ingredients Type
10.1. Baby Food Market, by Ingredients Type, 2023-2032
10.1.1. Fats and Oils
10.1.1.1. Market Revenue and Forecast (2021-2032)
10.1.2. Lactose
10.1.2.1. Market Revenue and Forecast (2021-2032)
10.1.3. Protein
10.1.3.1. Market Revenue and Forecast (2021-2032)
10.1.4. Flour
10.1.4.1. Market Revenue and Forecast (2021-2032)
10.1.5. Flavour Enhancer
10.1.5.1. Market Revenue and Forecast (2021-2032)
10.1.6. Vitamins & Minerals
10.1.6.1. Market Revenue and Forecast (2021-2032)
10.1.7. Others
10.1.7.1. Market Revenue and Forecast (2021-2032)
Chapter 11. Global Baby Food Market, By Formulation Type
11.1. Baby Food Market, by Formulation Type, 2023-2032
11.1.1. Powder
11.1.1.1. Market Revenue and Forecast (2021-2032)
11.1.2. Liquid
11.1.2.1. Market Revenue and Forecast (2021-2032)
Chapter 12. Global Baby Food Market, By Distribution Channel
12.1. Baby Food Market, by Distribution Channel, 2023-2032
12.1.1. Drugstores/ Pharmacies
12.1.1.1. Market Revenue and Forecast (2021-2032)
12.1.2. Supermarkets/Hypermarkets
12.1.2.1. Market Revenue and Forecast (2021-2032)
12.1.3. Online Channels
12.1.3.1. Market Revenue and Forecast (2021-2032)
12.1.4. Convenience Store
12.1.4.1. Market Revenue and Forecast (2021-2032)
12.1.5. Others
12.1.5.1. Market Revenue and Forecast (2021-2032)
Chapter 13. Global Baby Food Market, By Health Benefit
13.1. Baby Food Market, by Health Benefit Type, 2023-2032
13.1.1. Brain & Eye Development
13.1.1.1. Market Revenue and Forecast (2021-2032)
13.1.2. Muscular Growth
13.1.2.1. Market Revenue and Forecast (2021-2032)
13.1.3. Bones & Teeth Development
13.1.3.1. Market Revenue and Forecast (2021-2032)
13.1.4. Blood Enhancement
13.1.4.1. Market Revenue and Forecast (2021-2032)
13.1.5. Nervous System
13.1.5.1. Market Revenue and Forecast (2021-2032)
13.1.6. Vascular System
13.1.6.1. Market Revenue and Forecast (2021-2032)
13.1.7. Body Energy
13.1.7.1. Market Revenue and Forecast (2021-2032)
13.1.8. Others
13.1.8.1. Market Revenue and Forecast (2021-2032)
Chapter 14. Global Baby Food Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Category (2021-2032)
14.1.2. Market Revenue and Forecast, by Types (2021-2032)
14.1.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.1.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.1.5. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.1.6. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Category (2021-2032)
14.1.7.2. Market Revenue and Forecast, by Types (2021-2032)
14.1.7.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.1.7.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.1.8. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.1.8.1. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Category (2021-2032)
14.1.9.2. Market Revenue and Forecast, by Types (2021-2032)
14.1.9.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.1.9.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.1.10. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.1.11. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Category (2021-2032)
14.2.2. Market Revenue and Forecast, by Types (2021-2032)
14.2.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.2.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.2.5. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.2.6. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Category (2021-2032)
14.2.8.2. Market Revenue and Forecast, by Types (2021-2032)
14.2.8.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.2.9. Market Revenue and Forecast, by Formulation (2021-2032)
14.2.10. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.2.10.1. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Category (2021-2032)
14.2.11.2. Market Revenue and Forecast, by Types (2021-2032)
14.2.11.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.2.12. Market Revenue and Forecast, by Formulation (2021-2032)
14.2.13. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.2.14. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Category (2021-2032)
14.2.15.2. Market Revenue and Forecast, by Types (2021-2032)
14.2.15.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.2.15.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.2.16. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.2.16.1. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Category (2021-2032)
14.2.17.2. Market Revenue and Forecast, by Types (2021-2032)
14.2.17.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.2.17.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.2.18. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.2.18.1. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Category (2021-2032)
14.3.2. Market Revenue and Forecast, by Types (2021-2032)
14.3.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.3.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.3.5. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.3.6. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Category (2021-2032)
14.3.7.2. Market Revenue and Forecast, by Types (2021-2032)
14.3.7.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.3.7.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.3.8. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.3.9. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Category (2021-2032)
14.3.10.2. Market Revenue and Forecast, by Types (2021-2032)
14.3.10.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.3.10.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.3.11. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.3.11.1. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Category (2021-2032)
14.3.12.2. Market Revenue and Forecast, by Types (2021-2032)
14.3.12.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.3.12.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.3.12.5. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.3.12.6. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Category (2021-2032)
14.3.13.2. Market Revenue and Forecast, by Types (2021-2032)
14.3.13.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.3.13.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.3.13.5. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.3.13.6. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Category (2021-2032)
14.4.2. Market Revenue and Forecast, by Types (2021-2032)
14.4.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.4.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.4.5. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.4.6. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Category (2021-2032)
14.4.7.2. Market Revenue and Forecast, by Types (2021-2032)
14.4.7.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.4.7.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.4.8. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.4.9. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Category (2021-2032)
14.4.10.2. Market Revenue and Forecast, by Types (2021-2032)
14.4.10.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.4.10.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.4.11. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.4.12. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Category (2021-2032)
14.4.13.2. Market Revenue and Forecast, by Types (2021-2032)
14.4.13.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.4.13.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.4.13.5. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.4.13.6. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Category (2021-2032)
14.4.14.2. Market Revenue and Forecast, by Types (2021-2032)
14.4.14.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.4.14.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.4.14.5. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.4.14.6. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Category (2021-2032)
14.5.2. Market Revenue and Forecast, by Types (2021-2032)
14.5.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.5.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.5.5. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.5.6. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Category (2021-2032)
14.5.7.2. Market Revenue and Forecast, by Types (2021-2032)
14.5.7.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.5.7.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.5.8. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.5.8.1. Market Revenue and Forecast, by Health Benefit (2021-2032)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Category (2021-2032)
14.5.9.2. Market Revenue and Forecast, by Types (2021-2032)
14.5.9.3. Market Revenue and Forecast, by Ingredients (2021-2032)
14.5.9.4. Market Revenue and Forecast, by Formulation (2021-2032)
14.5.9.5. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.5.9.6. Market Revenue and Forecast, by Health Benefit (2021-2032)
Chapter 15. Company Profiles
15.1. Nestlé (Gerber Products Company)
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Danone S.A.
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Reckitt Benckiser (Mead Johnson & Company, LLC)
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Abbott
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Feihe International Inc.
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Fries land Campina
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Bellamy's Organic
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Kraft Heinz
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. HiPP GmbH & Co. Vertrieb KG
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Perrigo
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
15.11. Arla Food
15.11.1. Company Overview
15.11.2. Product Offerings
15.11.3. Financial Performance
15.11.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client